Dear Members of the Biotechnology Committee:
The AIPLA is deeply involved in the evaluation of treaties and laws related to the source of genetic materials, and needs our help.
Please let us know whether you are aware of circumstances in which a patent applicant was not granted a patent or a patent holder’s patent has been invalidated in China due to failure to comply with the patent law’s requirement to disclose the source of origin of genetic material used in the invention. I note that the patent law in China, in articles 5 and 26, refers to patent applications involving genetic resources:
https://www.wipo.int/edocs/lexdocs/laws/en/cn/cn028en.pdf
Thanks in advance